Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
AbstractObjectiveTo evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to reach underscreened women.DesignUpdated meta-analysis.Data sourcesMedline (PubMed), Embase, and CENTRAL from 1 January 2013 to 15 Apri...
Gespeichert in:
| Veröffentlicht in: | BMJ (Online) Jg. 363; S. k4823 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
British Medical Journal Publishing Group
05.12.2018
BMJ Publishing Group LTD BMJ Publishing Group Ltd |
| Schlagworte: | |
| ISSN: | 0959-8138, 1756-1833, 1756-1833 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | AbstractObjectiveTo evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to reach underscreened women.DesignUpdated meta-analysis.Data sourcesMedline (PubMed), Embase, and CENTRAL from 1 January 2013 to 15 April 2018 (accuracy review), and 1 January 2014 to 15 April 2018 (participation review).Review methodsAccuracy review: hrHPV assay on a vaginal self sample and a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation review: study population included women who were irregularly or never screened; women in the self sampling arm (intervention arm) were invited to collect a self sample for hrHPV testing; women in the control arm were invited or reminded to undergo a screening test on a clinician sample; participation in both arms was documented; and a population minimum of 400 women.Results56 accuracy studies and 25 participation trials were included. hrHPV assays based on polymerase chain reaction were as sensitive on self samples as on clinician samples to detect CIN2+ or CIN3+ (pooled ratio 0.99, 95% confidence interval 0.97 to 1.02). However, hrHPV assays based on signal amplification were less sensitive on self samples (pooled ratio 0.85, 95% confidence interval 0.80 to 0.89). The specificity to exclude CIN2+ was 2% or 4% lower on self samples than on clinician samples, for hrHPV assays based on polymerase chain reaction or signal amplification, respectively. Mailing self sample kits to the woman’s home address generated higher response rates to have a sample taken by a clinician than invitation or reminder letters (pooled relative participation in intention-to-treat-analysis of 2.33, 95% confidence interval 1.86 to 2.91). Opt-in strategies where women had to request a self sampling kit were generally not more effective than invitation letters (relative participation of 1.22, 95% confidence interval 0.93 to 1.61). Direct offer of self sampling devices to women in communities that were underscreened generated high participation rates (>75%). Substantial interstudy heterogeneity was noted (I2>95%).ConclusionsWhen used with hrHPV assays based on polymerase chain reaction, testing on self samples was similarly accurate as on clinician samples. Offering self sampling kits generally is more effective in reaching underscreened women than sending invitations. However, since response rates are highly variable among settings, pilots should be set up before regional or national roll out of self sampling strategies. |
|---|---|
| AbstractList | ObjectiveTo evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to reach underscreened women.DesignUpdated meta-analysis.Data sourcesMedline (PubMed), Embase, and CENTRAL from 1 January 2013 to 15 April 2018 (accuracy review), and 1 January 2014 to 15 April 2018 (participation review).Review methodsAccuracy review: hrHPV assay on a vaginal self sample and a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation review: study population included women who were irregularly or never screened; women in the self sampling arm (intervention arm) were invited to collect a self sample for hrHPV testing; women in the control arm were invited or reminded to undergo a screening test on a clinician sample; participation in both arms was documented; and a population minimum of 400 women.Results56 accuracy studies and 25 participation trials were included. hrHPV assays based on polymerase chain reaction were as sensitive on self samples as on clinician samples to detect CIN2+ or CIN3+ (pooled ratio 0.99, 95% confidence interval 0.97 to 1.02). However, hrHPV assays based on signal amplification were less sensitive on self samples (pooled ratio 0.85, 95% confidence interval 0.80 to 0.89). The specificity to exclude CIN2+ was 2% or 4% lower on self samples than on clinician samples, for hrHPV assays based on polymerase chain reaction or signal amplification, respectively. Mailing self sample kits to the woman’s home address generated higher response rates to have a sample taken by a clinician than invitation or reminder letters (pooled relative participation in intention-to-treat-analysis of 2.33, 95% confidence interval 1.86 to 2.91). Opt-in strategies where women had to request a self sampling kit were generally not more effective than invitation letters (relative participation of 1.22, 95% confidence interval 0.93 to 1.61). Direct offer of self sampling devices to women in communities that were underscreened generated high participation rates (>75%). Substantial interstudy heterogeneity was noted (I2>95%).ConclusionsWhen used with hrHPV assays based on polymerase chain reaction, testing on self samples was similarly accurate as on clinician samples. Offering self sampling kits generally is more effective in reaching underscreened women than sending invitations. However, since response rates are highly variable among settings, pilots should be set up before regional or national roll out of self sampling strategies. To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to reach underscreened women.OBJECTIVETo evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to reach underscreened women.Updated meta-analysis.DESIGNUpdated meta-analysis.Medline (PubMed), Embase, and CENTRAL from 1 January 2013 to 15 April 2018 (accuracy review), and 1 January 2014 to 15 April 2018 (participation review).DATA SOURCESMedline (PubMed), Embase, and CENTRAL from 1 January 2013 to 15 April 2018 (accuracy review), and 1 January 2014 to 15 April 2018 (participation review).Accuracy review: hrHPV assay on a vaginal self sample and a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation review: study population included women who were irregularly or never screened; women in the self sampling arm (intervention arm) were invited to collect a self sample for hrHPV testing; women in the control arm were invited or reminded to undergo a screening test on a clinician sample; participation in both arms was documented; and a population minimum of 400 women.REVIEW METHODSAccuracy review: hrHPV assay on a vaginal self sample and a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation review: study population included women who were irregularly or never screened; women in the self sampling arm (intervention arm) were invited to collect a self sample for hrHPV testing; women in the control arm were invited or reminded to undergo a screening test on a clinician sample; participation in both arms was documented; and a population minimum of 400 women.56 accuracy studies and 25 participation trials were included. hrHPV assays based on polymerase chain reaction were as sensitive on self samples as on clinician samples to detect CIN2+ or CIN3+ (pooled ratio 0.99, 95% confidence interval 0.97 to 1.02). However, hrHPV assays based on signal amplification were less sensitive on self samples (pooled ratio 0.85, 95% confidence interval 0.80 to 0.89). The specificity to exclude CIN2+ was 2% or 4% lower on self samples than on clinician samples, for hrHPV assays based on polymerase chain reaction or signal amplification, respectively. Mailing self sample kits to the woman's home address generated higher response rates to have a sample taken by a clinician than invitation or reminder letters (pooled relative participation in intention-to-treat-analysis of 2.33, 95% confidence interval 1.86 to 2.91). Opt-in strategies where women had to request a self sampling kit were generally not more effective than invitation letters (relative participation of 1.22, 95% confidence interval 0.93 to 1.61). Direct offer of self sampling devices to women in communities that were underscreened generated high participation rates (>75%). Substantial interstudy heterogeneity was noted (I2>95%).RESULTS56 accuracy studies and 25 participation trials were included. hrHPV assays based on polymerase chain reaction were as sensitive on self samples as on clinician samples to detect CIN2+ or CIN3+ (pooled ratio 0.99, 95% confidence interval 0.97 to 1.02). However, hrHPV assays based on signal amplification were less sensitive on self samples (pooled ratio 0.85, 95% confidence interval 0.80 to 0.89). The specificity to exclude CIN2+ was 2% or 4% lower on self samples than on clinician samples, for hrHPV assays based on polymerase chain reaction or signal amplification, respectively. Mailing self sample kits to the woman's home address generated higher response rates to have a sample taken by a clinician than invitation or reminder letters (pooled relative participation in intention-to-treat-analysis of 2.33, 95% confidence interval 1.86 to 2.91). Opt-in strategies where women had to request a self sampling kit were generally not more effective than invitation letters (relative participation of 1.22, 95% confidence interval 0.93 to 1.61). Direct offer of self sampling devices to women in communities that were underscreened generated high participation rates (>75%). Substantial interstudy heterogeneity was noted (I2>95%).When used with hrHPV assays based on polymerase chain reaction, testing on self samples was similarly accurate as on clinician samples. Offering self sampling kits generally is more effective in reaching underscreened women than sending invitations. However, since response rates are highly variable among settings, pilots should be set up before regional or national roll out of self sampling strategies.CONCLUSIONSWhen used with hrHPV assays based on polymerase chain reaction, testing on self samples was similarly accurate as on clinician samples. Offering self sampling kits generally is more effective in reaching underscreened women than sending invitations. However, since response rates are highly variable among settings, pilots should be set up before regional or national roll out of self sampling strategies. AbstractObjectiveTo evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to reach underscreened women.DesignUpdated meta-analysis.Data sourcesMedline (PubMed), Embase, and CENTRAL from 1 January 2013 to 15 April 2018 (accuracy review), and 1 January 2014 to 15 April 2018 (participation review).Review methodsAccuracy review: hrHPV assay on a vaginal self sample and a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation review: study population included women who were irregularly or never screened; women in the self sampling arm (intervention arm) were invited to collect a self sample for hrHPV testing; women in the control arm were invited or reminded to undergo a screening test on a clinician sample; participation in both arms was documented; and a population minimum of 400 women.Results56 accuracy studies and 25 participation trials were included. hrHPV assays based on polymerase chain reaction were as sensitive on self samples as on clinician samples to detect CIN2+ or CIN3+ (pooled ratio 0.99, 95% confidence interval 0.97 to 1.02). However, hrHPV assays based on signal amplification were less sensitive on self samples (pooled ratio 0.85, 95% confidence interval 0.80 to 0.89). The specificity to exclude CIN2+ was 2% or 4% lower on self samples than on clinician samples, for hrHPV assays based on polymerase chain reaction or signal amplification, respectively. Mailing self sample kits to the woman’s home address generated higher response rates to have a sample taken by a clinician than invitation or reminder letters (pooled relative participation in intention-to-treat-analysis of 2.33, 95% confidence interval 1.86 to 2.91). Opt-in strategies where women had to request a self sampling kit were generally not more effective than invitation letters (relative participation of 1.22, 95% confidence interval 0.93 to 1.61). Direct offer of self sampling devices to women in communities that were underscreened generated high participation rates (>75%). Substantial interstudy heterogeneity was noted (I2>95%).ConclusionsWhen used with hrHPV assays based on polymerase chain reaction, testing on self samples was similarly accurate as on clinician samples. Offering self sampling kits generally is more effective in reaching underscreened women than sending invitations. However, since response rates are highly variable among settings, pilots should be set up before regional or national roll out of self sampling strategies. To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to reach underscreened women. Updated meta-analysis. Medline (PubMed), Embase, and CENTRAL from 1 January 2013 to 15 April 2018 (accuracy review), and 1 January 2014 to 15 April 2018 (participation review). Accuracy review: hrHPV assay on a vaginal self sample and a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation review: study population included women who were irregularly or never screened; women in the self sampling arm (intervention arm) were invited to collect a self sample for hrHPV testing; women in the control arm were invited or reminded to undergo a screening test on a clinician sample; participation in both arms was documented; and a population minimum of 400 women. 56 accuracy studies and 25 participation trials were included. hrHPV assays based on polymerase chain reaction were as sensitive on self samples as on clinician samples to detect CIN2+ or CIN3+ (pooled ratio 0.99, 95% confidence interval 0.97 to 1.02). However, hrHPV assays based on signal amplification were less sensitive on self samples (pooled ratio 0.85, 95% confidence interval 0.80 to 0.89). The specificity to exclude CIN2+ was 2% or 4% lower on self samples than on clinician samples, for hrHPV assays based on polymerase chain reaction or signal amplification, respectively. Mailing self sample kits to the woman's home address generated higher response rates to have a sample taken by a clinician than invitation or reminder letters (pooled relative participation in intention-to-treat-analysis of 2.33, 95% confidence interval 1.86 to 2.91). Opt-in strategies where women had to request a self sampling kit were generally not more effective than invitation letters (relative participation of 1.22, 95% confidence interval 0.93 to 1.61). Direct offer of self sampling devices to women in communities that were underscreened generated high participation rates (>75%). Substantial interstudy heterogeneity was noted (I >95%). When used with hrHPV assays based on polymerase chain reaction, testing on self samples was similarly accurate as on clinician samples. Offering self sampling kits generally is more effective in reaching underscreened women than sending invitations. However, since response rates are highly variable among settings, pilots should be set up before regional or national roll out of self sampling strategies. |
| Author | Sultana, Farhana Castle, Philip Arbyn, Marc Smith, Sara B Temin, Sarah |
| Author_xml | – sequence: 1 givenname: Marc surname: Arbyn fullname: Arbyn, Marc email: marc.arbyn@sciensano.be organization: Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, J Wytsmanstreet 14, B1050 Brussels, Belgium – sequence: 2 givenname: Sara B surname: Smith fullname: Smith, Sara B organization: Global Coalition Against Cervical Cancer, Durham, NC, USA – sequence: 3 givenname: Sarah surname: Temin fullname: Temin, Sarah organization: Department of Cancer Policy and Advocacy, American Society of Clinical Oncology, Alexandria, VA, USA – sequence: 4 givenname: Farhana surname: Sultana fullname: Sultana, Farhana organization: Registries and Research, Victorian Cytology Service Registries, Victorian Cytology Service Ltd, Carlton South, Australia – sequence: 5 givenname: Philip surname: Castle fullname: Castle, Philip organization: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30518635$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkUtv1DAUhS1URIfSBX8AWUJIsEjrR-w4LJBQeRSpEiyArXXj3LQZEntqJ0Xz73E6ZQSFlXV9v3N0rs5jcuCDR0KecnbCudSnzbg--VEaIR-QFa-ULriR8oCsWK3qwnBpDslxSmvGmJCVqbV6RA4lU9xoqVZk-w4ndFPvL6nDeNM7GOgmogOfRwq-pRHBXS372bcYk4uIHlv6M4zoabOlc1qW51--0wnTrVHwNOHQ0QTjZsD0ms6bFqasGXGCAjwM24TpCXnYwZDw-O49It8-vP96dl5cfP746eztRdGUUk4FKHBa607pRjc1MFahKuvOVFzULRcdq7FytXFKl23H2qoxogTlhAHs6rY08oi82flu5mbE1qGfIgx2E_sR4tYG6O3fG99f2ctwY7WojDJVNnh5ZxDD9ZxvtGOfHA4DeAxzsoJrzrRQrMzo83voOswxH7xQiomaGaYy9ezPRPsov1vJwKsd4GJIKWK3RzizS-k2l25vS8_s6T3W9RNMfViO6Yf_Kl7sFMvXPt-_3C8QDL04 |
| CitedBy_id | crossref_primary_10_1136_bmjopen_2022_068940 crossref_primary_10_3390_pathogens12091169 crossref_primary_10_1016_j_ypmed_2021_106623 crossref_primary_10_1002_ijgo_13455 crossref_primary_10_3389_fonc_2025_1633894 crossref_primary_10_1080_14760584_2022_2008243 crossref_primary_10_1097_QAD_0000000000003437 crossref_primary_10_3389_fpubh_2022_938272 crossref_primary_10_1016_j_jcv_2020_104375 crossref_primary_10_1111_jep_13258 crossref_primary_10_1089_whr_2021_0074 crossref_primary_10_3390_cancers14235913 crossref_primary_10_1200_GO_20_00598 crossref_primary_10_3389_fpubh_2024_1439164 crossref_primary_10_1186_s12889_024_19881_0 crossref_primary_10_1177_0956462419868618 crossref_primary_10_1177_09691413221092246 crossref_primary_10_1097_AOG_0000000000005393 crossref_primary_10_1097_AOG_0000000000006003 crossref_primary_10_1007_s10552_024_01852_w crossref_primary_10_1097_GCO_0000000000000979 crossref_primary_10_1002_jmv_29283 crossref_primary_10_1371_journal_pone_0286909 crossref_primary_10_1002_ijc_33905 crossref_primary_10_1016_j_ypmed_2020_106322 crossref_primary_10_1038_s41591_023_02600_4 crossref_primary_10_3390_curroncol32070407 crossref_primary_10_1016_j_mcna_2020_08_006 crossref_primary_10_3390_diagnostics12061508 crossref_primary_10_1186_s13027_020_00311_w crossref_primary_10_1016_j_jcv_2021_104756 crossref_primary_10_1093_jncics_pkad103 crossref_primary_10_1136_bmjgh_2018_001351 crossref_primary_10_1186_s12889_024_17723_7 crossref_primary_10_1016_j_heliyon_2024_e31032 crossref_primary_10_7759_cureus_65555 crossref_primary_10_1097_GRF_0000000000000793 crossref_primary_10_1371_journal_pmed_1004253 crossref_primary_10_1371_journal_pmed_1004494 crossref_primary_10_1016_j_jcpo_2025_100642 crossref_primary_10_1158_1940_6207_CAPR_21_0016 crossref_primary_10_3390_diagnostics12123075 crossref_primary_10_1016_j_ypmed_2020_106314 crossref_primary_10_7554_eLife_80905 crossref_primary_10_1128_spectrum_02872_23 crossref_primary_10_3389_fpubh_2025_1535122 crossref_primary_10_1016_j_ajog_2020_06_006 crossref_primary_10_1007_s40615_024_01963_9 crossref_primary_10_1371_journal_pmed_1004143 crossref_primary_10_1186_s12916_025_04149_0 crossref_primary_10_1016_j_path_2024_04_006 crossref_primary_10_1155_2024_6651272 crossref_primary_10_1093_jnci_djaa089 crossref_primary_10_2196_14652 crossref_primary_10_1111_ajo_13906 crossref_primary_10_3390_healthcare10030459 crossref_primary_10_1186_s12905_020_00921_x crossref_primary_10_3390_diagnostics15091176 crossref_primary_10_1038_s41416_025_03102_5 crossref_primary_10_1038_s41416_022_01954_9 crossref_primary_10_1111_hex_13961 crossref_primary_10_1186_s13027_024_00583_6 crossref_primary_10_3389_fmicb_2023_1194431 crossref_primary_10_1016_j_ypmed_2020_106410 crossref_primary_10_1200_GO_22_00217 crossref_primary_10_1016_j_ypmed_2021_106831 crossref_primary_10_1016_j_lanwpc_2021_100265 crossref_primary_10_3390_ijms26031296 crossref_primary_10_1097_GCO_0000000000000542 crossref_primary_10_1089_whr_2024_0180 crossref_primary_10_1186_s12905_023_02557_z crossref_primary_10_3390_cancers17010063 crossref_primary_10_1186_s43058_022_00367_2 crossref_primary_10_1016_j_clinmicnews_2023_08_002 crossref_primary_10_1016_j_canep_2020_101849 crossref_primary_10_2147_IJWH_S474571 crossref_primary_10_3390_healthcare11091323 crossref_primary_10_3390_medsci10010016 crossref_primary_10_63501_mrrfq130 crossref_primary_10_1007_s11606_021_07193_7 crossref_primary_10_1186_s12905_023_02215_4 crossref_primary_10_3390_diagnostics15091079 crossref_primary_10_4103_0970_258X_323447 crossref_primary_10_47102_annals_acadmedsg_20255 crossref_primary_10_47102_annals_acadmedsg_20252 crossref_primary_10_1136_sextrans_2019_054052 crossref_primary_10_1002_cncr_32154 crossref_primary_10_1016_j_ygyno_2019_06_002 crossref_primary_10_1016_j_cmi_2019_09_006 crossref_primary_10_2478_raon_2021_0001 crossref_primary_10_1007_s12672_025_02432_3 crossref_primary_10_1186_s12879_020_05663_7 crossref_primary_10_1200_EDBK_325319 crossref_primary_10_1186_s12905_023_02423_y crossref_primary_10_1186_s12916_023_02840_8 crossref_primary_10_3389_fmed_2025_1567509 crossref_primary_10_1136_bmj_2021_068776 crossref_primary_10_3390_ijerph181910050 crossref_primary_10_1002_cam4_4152 crossref_primary_10_1038_s41598_021_87329_1 crossref_primary_10_1016_j_canep_2023_102369 crossref_primary_10_1186_s12913_023_10040_6 crossref_primary_10_3390_healthcare12050599 crossref_primary_10_1016_j_clinmicnews_2023_10_003 crossref_primary_10_1071_SH23210 crossref_primary_10_1002_ijgo_70074 crossref_primary_10_1001_jamanetworkopen_2025_11081 crossref_primary_10_1071_PY25101 crossref_primary_10_1186_s12885_019_5477_8 crossref_primary_10_1093_fampra_cmae078 crossref_primary_10_1097_MS9_0000000000001529 crossref_primary_10_1136_bmjopen_2024_086099 crossref_primary_10_1016_j_jmoldx_2023_06_004 crossref_primary_10_1177_17455065221075905 crossref_primary_10_1016_j_mcna_2022_10_006 crossref_primary_10_1038_s41416_022_02094_w crossref_primary_10_1017_S1463423623000713 crossref_primary_10_1038_s41598_024_79472_2 crossref_primary_10_1002_ijc_33967 crossref_primary_10_1136_bmjopen_2023_080395 crossref_primary_10_1002_jmv_26043 crossref_primary_10_1111_1471_0528_16503 crossref_primary_10_1002_cncr_34157 crossref_primary_10_5888_pcd21_230234 crossref_primary_10_1016_j_pharma_2022_09_006 crossref_primary_10_1136_bmj_l361 crossref_primary_10_1186_s12905_020_01158_4 crossref_primary_10_1038_s41598_025_09292_5 crossref_primary_10_1080_14787210_2019_1668776 crossref_primary_10_3390_healthcare12171704 crossref_primary_10_1136_bmjsrh_2024_202536 crossref_primary_10_3322_caac_21696 crossref_primary_10_1001_jamanetworkopen_2022_15490 crossref_primary_10_3390_ijerph182010820 crossref_primary_10_5798_dicletip_1313386 crossref_primary_10_7554_eLife_86266 crossref_primary_10_1002_ijc_33850 crossref_primary_10_1089_jwh_2019_7678 crossref_primary_10_1016_j_ypmed_2021_106900 crossref_primary_10_1002_ijc_32881 crossref_primary_10_1177_10732748221102819 crossref_primary_10_1111_1467_9566_13421 crossref_primary_10_1016_j_cmi_2021_04_031 crossref_primary_10_1093_jjco_hyab109 crossref_primary_10_54235_27382737_2023_v3_2_36 crossref_primary_10_3390_life10110290 crossref_primary_10_7554_eLife_91469_3 crossref_primary_10_1177_21501319251320178 crossref_primary_10_7326_ACPJ201907160_002 crossref_primary_10_3322_caac_21557 crossref_primary_10_1186_s12916_025_04246_0 crossref_primary_10_1186_s13027_020_00280_0 crossref_primary_10_3390_cancers17020190 crossref_primary_10_1111_hex_14118 crossref_primary_10_1002_ijc_33879 crossref_primary_10_3390_curroncol32060327 crossref_primary_10_1016_j_jviromet_2019_04_015 crossref_primary_10_1126_scitranslmed_abn4768 crossref_primary_10_1016_j_respe_2023_101838 crossref_primary_10_1186_s12905_022_01944_2 crossref_primary_10_2217_fvl_2021_0246 crossref_primary_10_3322_caac_21660 crossref_primary_10_1016_j_jpp_2021_02_003 crossref_primary_10_3390_cancers14122913 crossref_primary_10_1071_HC24118 crossref_primary_10_1186_s12985_020_01420_z crossref_primary_10_1001_jamainternmed_2025_2971 crossref_primary_10_1371_journal_pone_0292605 crossref_primary_10_1071_HC24110 crossref_primary_10_1002_ijc_33888 crossref_primary_10_1111_aogs_15112 crossref_primary_10_1136_bmjopen_2023_081282 crossref_primary_10_1186_s12905_025_03652_z crossref_primary_10_1002_cam4_5851 crossref_primary_10_1186_s13643_023_02252_y crossref_primary_10_1007_s40944_021_00539_3 crossref_primary_10_1002_ijc_34970 crossref_primary_10_1038_s41598_023_29255_y crossref_primary_10_1016_j_lana_2022_100199 crossref_primary_10_1111_cmi_13397 crossref_primary_10_1186_s43058_021_00243_5 crossref_primary_10_1016_j_jogn_2019_08_001 crossref_primary_10_1002_ijc_33533 crossref_primary_10_2196_38917 crossref_primary_10_1016_j_arcmed_2024_103009 crossref_primary_10_2147_RMHP_S296914 crossref_primary_10_1002_ijc_34989 crossref_primary_10_3390_cancers16112066 crossref_primary_10_1371_journal_pone_0229086 crossref_primary_10_1128_jcm_01852_24 crossref_primary_10_1177_1745506520914804 crossref_primary_10_1089_whr_2024_0102 crossref_primary_10_1371_journal_pntd_0008337 crossref_primary_10_1136_bmjebm_2024_112959 crossref_primary_10_1016_j_amepre_2023_10_020 crossref_primary_10_1016_j_revmed_2024_11_001 crossref_primary_10_1016_j_arcmed_2025_103316 crossref_primary_10_1016_j_jcv_2021_105017 crossref_primary_10_1017_cts_2023_578 crossref_primary_10_1002_ijc_34754 crossref_primary_10_1016_j_semradonc_2021_02_011 crossref_primary_10_5694_mja2_51262 crossref_primary_10_1136_bmj_o1303 crossref_primary_10_1111_aogs_14162 crossref_primary_10_3390_cancers13071640 crossref_primary_10_1002_cncr_35269 crossref_primary_10_1177_09691413211052499 crossref_primary_10_1016_j_jiph_2025_102809 crossref_primary_10_1007_s11657_019_0603_4 crossref_primary_10_1136_bmjsrh_2023_202023 crossref_primary_10_2147_IJWH_S416520 crossref_primary_10_1093_eurpub_ckae075 crossref_primary_10_2217_fon_2020_0928 crossref_primary_10_1093_eurpub_ckaf045 crossref_primary_10_1080_26410397_2021_2005283 crossref_primary_10_1111_hex_70338 crossref_primary_10_1002_cam4_3468 crossref_primary_10_1155_ogi_9344596 crossref_primary_10_1371_journal_pone_0312295 crossref_primary_10_1186_s13027_020_00324_5 crossref_primary_10_1186_s13027_024_00623_1 crossref_primary_10_5694_mja2_51137 crossref_primary_10_1001_jama_2023_21471 crossref_primary_10_3389_fonc_2024_1383105 crossref_primary_10_3390_vaccines8020175 crossref_primary_10_1089_whr_2024_0004 crossref_primary_10_1016_j_whi_2024_05_005 crossref_primary_10_3390_cancers15215163 crossref_primary_10_1001_jamanetworkopen_2023_26890 crossref_primary_10_1186_s12889_019_7354_4 crossref_primary_10_1186_s13027_023_00536_5 crossref_primary_10_1016_j_lana_2021_100160 crossref_primary_10_1016_j_ygyno_2021_06_010 crossref_primary_10_3390_cancers17132072 crossref_primary_10_1002_jmv_70273 crossref_primary_10_1089_jwh_2019_8258 crossref_primary_10_3390_v15091889 crossref_primary_10_1097_AOG_0000000000005960 crossref_primary_10_3389_fmicb_2025_1540609 crossref_primary_10_1016_j_ejim_2025_01_002 crossref_primary_10_1089_jwh_2019_8132 crossref_primary_10_1136_bmjopen_2019_035796 crossref_primary_10_3389_fpubh_2022_875177 crossref_primary_10_1016_j_gofs_2019_09_004 crossref_primary_10_1136_bmjopen_2024_092701 crossref_primary_10_1093_ofid_ofad540 crossref_primary_10_1186_s12905_023_02475_0 crossref_primary_10_3389_fneur_2023_1119660 crossref_primary_10_1186_s43058_023_00436_0 crossref_primary_10_1016_j_cmi_2020_03_018 crossref_primary_10_1136_bmjgh_2021_007380 crossref_primary_10_2217_epi_2019_0331 crossref_primary_10_1136_bmjopen_2024_095091 crossref_primary_10_1186_s12905_022_01634_z crossref_primary_10_3390_cancers14112612 crossref_primary_10_1186_s12889_024_18551_5 crossref_primary_10_3390_ijerph19084619 crossref_primary_10_3390_ijerph19010054 crossref_primary_10_3389_fonc_2022_1020205 crossref_primary_10_1111_medu_14737 crossref_primary_10_1097_01_PGO_0000579548_37054_ed crossref_primary_10_1128_spectrum_01207_23 crossref_primary_10_3390_cancers16111986 crossref_primary_10_1002_jmv_70254 crossref_primary_10_3389_fonc_2023_1243888 crossref_primary_10_1590_0037_8682_0277_2023 crossref_primary_10_1002_hpja_708 crossref_primary_10_1186_s13643_020_01538_9 crossref_primary_10_1371_journal_pone_0277791 crossref_primary_10_1177_09691413241268819 crossref_primary_10_3322_caac_21834 crossref_primary_10_1002_ijc_32374 crossref_primary_10_1093_eurpub_ckad055 crossref_primary_10_1371_journal_pone_0241781 crossref_primary_10_1093_eurpub_ckaf122 crossref_primary_10_1111_cyt_13026 crossref_primary_10_1016_j_jcv_2022_105349 crossref_primary_10_1016_j_ygyno_2021_06_020 crossref_primary_10_1001_jamanetworkopen_2019_14729 crossref_primary_10_1038_s41416_020_0920_9 crossref_primary_10_7554_eLife_91469 crossref_primary_10_1016_j_gofs_2024_06_004 crossref_primary_10_1007_s10900_023_01190_z crossref_primary_10_1128_jcm_01403_22 crossref_primary_10_3390_jcm10214817 crossref_primary_10_1080_14796694_2024_2409625 crossref_primary_10_1038_s41416_022_02038_4 crossref_primary_10_1007_s40944_024_00876_z crossref_primary_10_1002_cncy_70006 crossref_primary_10_1080_16549716_2020_1838240 crossref_primary_10_1177_09691413221080635 crossref_primary_10_1002_jmv_70079 crossref_primary_10_1097_CEJ_0000000000000693 crossref_primary_10_1007_s13187_024_02565_z crossref_primary_10_1002_ijc_33482 crossref_primary_10_3389_fpubh_2022_1003461 crossref_primary_10_1158_1940_6207_CAPR_23_0134 crossref_primary_10_1186_s13690_021_00667_4 crossref_primary_10_1002_ijc_33001 crossref_primary_10_1017_S1463423623000191 crossref_primary_10_1001_jamanetworkopen_2022_44343 crossref_primary_10_3390_cancers15102797 crossref_primary_10_1016_j_healthpol_2024_105077 crossref_primary_10_1007_s40615_023_01516_6 crossref_primary_10_1186_s12916_023_03186_x crossref_primary_10_1371_journal_pntd_0011465 crossref_primary_10_3390_diagnostics13213297 crossref_primary_10_1111_1471_0528_18159 crossref_primary_10_1136_bmjgh_2025_019041 crossref_primary_10_3390_healthcare12212160 crossref_primary_10_3390_cancers15061669 crossref_primary_10_12688_wellcomeopenres_15482_1 crossref_primary_10_12688_wellcomeopenres_15482_2 crossref_primary_10_1080_14737159_2020_1835472 crossref_primary_10_3390_v16091357 crossref_primary_10_1002_ijc_34358 crossref_primary_10_1002_jmv_29649 crossref_primary_10_1016_j_jcv_2024_105737 crossref_primary_10_1136_bmjopen_2022_061650 crossref_primary_10_31435_ijitss_3_47__2025_3569 crossref_primary_10_1089_jwh_2021_0597 crossref_primary_10_3389_fpubh_2021_670032 crossref_primary_10_1136_bmjopen_2019_035153 crossref_primary_10_1016_j_pathol_2020_10_006 crossref_primary_10_1186_s12905_024_03301_x crossref_primary_10_1186_s12879_024_10150_4 crossref_primary_10_1016_j_jnma_2023_02_006 crossref_primary_10_1016_j_ypmed_2020_106076 crossref_primary_10_1186_s12916_025_04131_w crossref_primary_10_3389_fmed_2023_1060451 crossref_primary_10_3390_cancers12041053 crossref_primary_10_1186_s13063_019_3959_2 crossref_primary_10_1186_s12905_022_01851_6 crossref_primary_10_1186_s12905_023_02691_8 crossref_primary_10_1051_bioconf_20236505006 crossref_primary_10_1038_s41591_023_02577_0 crossref_primary_10_5694_mja2_51412 crossref_primary_10_1016_j_jcv_2022_105271 crossref_primary_10_1177_10732748251330698 crossref_primary_10_1016_j_ejogrb_2021_11_430 crossref_primary_10_1200_GO_21_00033 crossref_primary_10_1089_whr_2025_0017 crossref_primary_10_1186_s12885_019_6401_y crossref_primary_10_1056_NEJMsr2030640 crossref_primary_10_1186_s12889_022_14222_5 crossref_primary_10_1128_spectrum_00081_23 crossref_primary_10_1186_s12905_022_01916_6 crossref_primary_10_1200_GO_21_00161 crossref_primary_10_1002_ijc_34013 crossref_primary_10_3389_fmed_2025_1580665 crossref_primary_10_15585_mmwr_mm7004a1 crossref_primary_10_1136_bmj_l1357 crossref_primary_10_1038_s41416_023_02277_z crossref_primary_10_1016_j_ypmed_2021_106596 crossref_primary_10_1097_CEJ_0000000000000701 crossref_primary_10_1016_j_lanwpc_2023_100860 crossref_primary_10_1186_s12905_021_01356_8 crossref_primary_10_1093_jalm_jfaa238 crossref_primary_10_1089_whr_2025_0006 crossref_primary_10_5306_wjco_v16_i5_105055 crossref_primary_10_1016_j_jcv_2024_105649 crossref_primary_10_3389_fonc_2022_948471 crossref_primary_10_3390_ijerph19063531 crossref_primary_10_1016_j_ypmed_2020_106293 crossref_primary_10_1016_j_jinf_2020_05_006 crossref_primary_10_3389_fonc_2025_1567305 crossref_primary_10_3389_fpubh_2022_980899 crossref_primary_10_1136_bmjopen_2020_041512 crossref_primary_10_3390_ijerph19052610 crossref_primary_10_1177_0969141319885994 crossref_primary_10_1111_1471_0528_17295 crossref_primary_10_3390_ijerph17176245 crossref_primary_10_1111_1471_0528_18262 crossref_primary_10_3390_ijerph181910388 crossref_primary_10_1002_ijc_35369 crossref_primary_10_1186_s12919_021_00217_4 crossref_primary_10_1186_s12889_023_15402_7 crossref_primary_10_1016_j_ypmed_2021_106681 crossref_primary_10_1158_1940_6207_CAPR_19_0192 crossref_primary_10_1186_s12913_023_09022_5 crossref_primary_10_1186_s12905_023_02504_y crossref_primary_10_3390_healthcare10071270 crossref_primary_10_3390_jpm12121949 crossref_primary_10_1136_bmjopen_2020_039636 crossref_primary_10_1371_journal_pone_0283145 crossref_primary_10_1002_ijc_33189 crossref_primary_10_1016_j_pec_2023_107993 crossref_primary_10_25040_ntsh2025_01_01 crossref_primary_10_1158_1940_6207_CAPR_18_0419 crossref_primary_10_1002_hsr2_71005 crossref_primary_10_1016_j_ypmed_2020_106276 crossref_primary_10_3390_diagnostics14192194 crossref_primary_10_1002_ijc_34041 crossref_primary_10_1002_ijc_35133 crossref_primary_10_1093_eurpub_ckad229 crossref_primary_10_1111_hex_13707 crossref_primary_10_1200_GO_20_00061 crossref_primary_10_1111_jrh_12590 crossref_primary_10_3389_ijph_2022_1604284 crossref_primary_10_1016_j_ogc_2022_08_008 crossref_primary_10_1200_JGO_19_00202 crossref_primary_10_3390_healthcare11162273 crossref_primary_10_1002_ijgo_70207 crossref_primary_10_1016_j_ypmed_2020_106382 crossref_primary_10_1002_ijc_35263 crossref_primary_10_1128_spectrum_01631_22 crossref_primary_10_1071_SH24033 crossref_primary_10_1097_JXX_0000000000000923 crossref_primary_10_1002_ijc_34170 crossref_primary_10_1158_1078_0432_CCR_21_3710 crossref_primary_10_1002_pon_5272 crossref_primary_10_1097_EBP_0000000000001058 crossref_primary_10_3390_ijerph192315776 crossref_primary_10_1136_bmjsrh_2022_201526 crossref_primary_10_1016_j_jogc_2023_02_012 crossref_primary_10_1186_s12913_020_05214_5 crossref_primary_10_1200_GO_22_00297 crossref_primary_10_1158_1940_6207_CAPR_21_0110 crossref_primary_10_1016_j_jcv_2020_104445 crossref_primary_10_3390_cancers16234071 crossref_primary_10_1016_j_clinsp_2025_100780 crossref_primary_10_1002_btm2_10653 crossref_primary_10_1371_journal_pone_0250426 crossref_primary_10_1158_1055_9965_EPI_25_0362 crossref_primary_10_1136_bmj_l1375 crossref_primary_10_1002_cam4_7254 crossref_primary_10_1080_14737167_2025_2451732 crossref_primary_10_5694_mja2_50736 crossref_primary_10_1089_jwh_2020_8918 crossref_primary_10_1128_jcm_01404_24 crossref_primary_10_3390_cancers14194820 crossref_primary_10_1186_s12889_020_08601_z crossref_primary_10_3389_fpubh_2025_1524796 crossref_primary_10_1177_00333549241299272 crossref_primary_10_1016_j_jmoldx_2021_12_009 crossref_primary_10_1002_jmv_70466 crossref_primary_10_1158_1940_6207_CAPR_21_0578 crossref_primary_10_1016_j_jmoldx_2023_09_008 crossref_primary_10_3390_ijms25115736 crossref_primary_10_1002_ijgo_13485 crossref_primary_10_1200_GO_25_00037 crossref_primary_10_1021_acsnano_5c04309 crossref_primary_10_3389_fmedt_2025_1458857 crossref_primary_10_1136_sextrans_2022_055408 crossref_primary_10_3390_cancers16203475 crossref_primary_10_2147_IJWH_S288376 |
| Cites_doi | 10.1016/j.ejogrb.2010.12.023 10.1016/j.ygyno.2006.03.021 10.1258/096914107780154486 10.1016/S0140-6736(11)61522-5 10.1136/bmjopen-2017-016309 10.1099/vir.0.18995-0 10.1016/j.jcv.2012.02.022 10.1136/bmj.c1040 10.1177/1536867X0800800403 10.1002/ijc.30647 10.1136/bmj.g5264 10.1158/1055-9965.EPI-04-0569 10.1002/ijc.22484 10.1016/S0140-6736(99)04110-0 10.1097/IGC.0000000000000084 10.1186/2049-3258-72-39 10.1128/JCM.03195-13 10.1158/1055-9965.EPI-11-0307 10.1158/1538-7445.AM2014-4135 10.1136/bmj.327.7414.557 10.1016/j.jcv.2013.06.029 10.3747/co.25.3915 10.1002/ijc.27790 10.1016/j.vaccine.2013.02.071 10.1016/j.vaccine.2012.06.095 10.1016/S0002-9378(11)91637-8 10.1177/1536867X0900900202 10.1016/j.jcv.2018.08.006 10.1371/journal.pone.0151978 10.1016/j.jcv.2016.11.002 10.1007/s10552-015-0603-7 10.7314/APJCP.2014.15.17.7085 10.1001/jama.283.1.81 10.1016/j.ygyno.2005.11.030 10.1097/IGC.0b013e318280f3bc 10.1007/s10096-014-2147-2 10.1038/bjc.2014.510 10.1016/j.jclinepi.2005.01.016 10.1038/sj.bjc.6606040 10.1016/j.jcv.2017.12.008 10.1001/jama.2018.10897 10.1016/j.jcv.2016.06.016 10.1016/j.ijgo.2006.07.012 10.1258/jms.2012.012081 10.1007/BF03405681 10.1136/bmjopen-2016-011754 10.1016/j.canep.2009.10.013 10.3747/co.25.3916 10.1136/jcp.55.6.435 10.1016/S0140-6736(13)62218-7 10.1002/ijc.31391 10.1158/1055-9965.EPI-17-0534 10.1371/journal.pone.0092615 10.1684/bdc.2011.1388 10.1111/jog.13132 10.1038/bjc.2011.48 10.1007/s10096-017-3179-1 10.1177/0969141317696518 10.1097/OLQ.0000000000000345 10.1136/bmj.d5928 10.1371/journal.pone.0181905 10.1002/ijc.31261 10.1158/1940-6207.CAPR-13-0091 10.1002/ijc.26202 10.1016/j.jviromet.2013.05.009 10.1097/OLQ.0000000000000125 10.1093/jnci/djr532 10.1093/biostatistics/kxl004 10.1097/01.cej.0000220630.08352.7a 10.1136/bmjopen-2015-010660 10.1016/j.jcv.2018.02.002 10.1002/ijc.26128 10.1016/S1470-2045(13)70570-9 10.1016/j.jcv.2013.02.016 10.1016/S2214-109X(14)70354-7 10.1128/JCM.01506-12 10.4238/gmr.15027896 10.1016/j.puhe.2015.02.021 10.1177/1536867X0900900203 10.1016/0197-2456(86)90046-2 10.1177/1536867X0800800102 10.1016/j.jviromet.2012.11.010 10.1089/jwh.2015.5348 10.1067/mob.2002.122390 10.1111/aogs.12032 10.1016/j.jcv.2011.05.006 10.1023/A:1024806707399 10.1186/1471-2407-12-551 10.1006/gyno.2001.6370 10.1016/S1470-2045(08)70210-9 10.1097/LGT.0b013e3181cd6d36 10.1016/j.ygyno.2012.10.006 10.1038/bjc.2011.236 10.1002/ijc.28545 10.1007/s00428-012-1242-y 10.1016/j.jcv.2012.09.002 10.1016/j.ejca.2015.07.006 10.1002/ijc.30031 10.1038/bjc.2017.485 10.1177/0969141314558785 10.1111/1471-0528.14682 10.7326/0003-4819-151-4-200908180-00135 10.1038/bjc.2015.11 10.1038/sj.bjc.6605194 10.1186/s12885-018-4165-4 10.1002/ijc.22131 10.7326/0003-4819-155-8-201110180-00009 10.1016/j.cmi.2015.04.015 10.1111/jog.13258 10.1093/jnci/dju400 10.1128/JCM.02440-05 10.1002/ijc.25731 10.1111/tmi.12549 10.1186/s13027-017-0123-z 10.1002/ijc.25525 10.1093/annonc/mdr015 10.1016/j.ejca.2009.07.018 |
| ContentType | Journal Article |
| Copyright | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ |
| Copyright_xml | – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ |
| CorporateAuthor | Collaboration on Self-Sampling and HPV Testing |
| CorporateAuthor_xml | – name: Collaboration on Self-Sampling and HPV Testing |
| DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88I 8AF 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ASE AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH HCIFZ K6X K9. KB0 LK8 M2O M2P M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1136/bmj.k4823 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials ProQuest : Biological Science Collection journals [unlimited simultaneous users] ProQuest Central Natural Science Collection BMJ Journals ProQuest One Community College ProQuest Central British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep SciTech Premium Collection British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Research Library Science Database Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Databases ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition British Nursing Index with Full Text British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Research Library Prep MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1756-1833 |
| ExternalDocumentID | PMC6278587 30518635 10_1136_bmj_k4823 bmj |
| Genre | Meta-Analysis Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | Bhutan Australia United States--US Europe |
| GeographicLocations_xml | – name: Bhutan – name: Europe – name: United States--US – name: Australia |
| GroupedDBID | 23N 39C 4.4 40O 53G 5GY 7RV 7X7 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8G5 9YT AACGO AANCE AAWJN ABBHK ABIVO ABJNI ABPLY ABTLG ABUWG ABVAJ ABXSQ ACGFS ACGOD ACHIC ACMFJ ACMMV ACPRK ADQXQ ADULT AEUPB AEXZC AFKRA AGFXO AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS AQVQM AZQEC BBNVY BENPR BHPHI BPHCQ BTHHO C45 CCPQU CS3 DCCCD DWQXO EBS EJD F5P FYUFA GNUQQ GUQSH H13 HAJ HCIFZ HMCUK HZ~ IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST L7B LK8 M2O M2P M7P NAPCQ NXWIF O9- OVD PHGZT PQQKQ PROAC R53 RHI RMJ RV8 SA0 TEORI UKHRP VVN WOQ YFH YQY AAYXX AFFHD AN0 CITATION IAG IBB IMI PHGZM PJZUB PPXIY PQGLB 0R~ ADIXU CGR CUY CVF DOOOF ECM EIF NPM RHF 3V. 7XB 8FK ASE FPQ K6X K9. MBDVC PKEHL PQEST PQUKI PRINS PUEGO Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-b433t-a5ac666f56b6b9a007e549f87129d12f09e7c98c564df0d7b824a5c28aef9d483 |
| IEDL.DBID | M2O |
| ISICitedReferencesCount | 605 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000452846800003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0959-8138 1756-1833 |
| IngestDate | Tue Nov 04 01:39:26 EST 2025 Wed Oct 01 13:08:27 EDT 2025 Mon Sep 08 13:52:21 EDT 2025 Wed Feb 19 02:30:40 EST 2025 Sat Nov 29 04:33:50 EST 2025 Tue Nov 18 22:09:23 EST 2025 Thu Apr 24 22:50:57 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b433t-a5ac666f56b6b9a007e549f87129d12f09e7c98c564df0d7b824a5c28aef9d483 |
| Notes | ObjectType-Article-1 ObjectType-Evidence Based Healthcare-3 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC6278587 |
| PMID | 30518635 |
| PQID | 2150290805 |
| PQPubID | 2043523 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6278587 proquest_miscellaneous_2161062504 proquest_journals_2150290805 pubmed_primary_30518635 crossref_primary_10_1136_bmj_k4823 crossref_citationtrail_10_1136_bmj_k4823 bmj_journals_10_1136_bmj_k4823 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-12-05 |
| PublicationDateYYYYMMDD | 2018-12-05 |
| PublicationDate_xml | – month: 12 year: 2018 text: 2018-12-05 day: 05 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMJ (Online) |
| PublicationTitleAbbrev | BMJ |
| PublicationTitleAlternate | BMJ |
| PublicationYear | 2018 |
| Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group Ltd |
| Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group Ltd |
| References | Koliopoulos, Nyaga, Santesso (ref19) 2017; 8 Sasieni, Castanon (ref8) 2012; 19 Chen, Du, Zhang (ref51) 2016; 15 Sancho-Garnier, Tamalet, Halfon (ref112) 2013; 133 Harris, Bradburn, Deeks, Harbord, Altman, Sterne (ref40) 2008; 8 Racey, Gesink, Burchell, Trivers, Wong, Rebbapragada (ref64) 2016; 25 Brink, Meijer, Wiegerinck (ref79) 2006; 44 Ronco, Dillner, Elfström (ref20) 2014; 383 Nyaga, Arbyn, Aerts (ref38) 2014; 72 Bray, Lortet-Tieulent, Znaor, Brotons, Poljak, Arbyn (ref6) 2013; 31 Vorsters, Van den Bergh, Micalessi (ref122) 2014; 33 Baldur-Felskov, Munk, Nielsen (ref9) 2015; 26 Chen, Ouyang, Hillemanns, Jentschke (ref52) 2016; 42 Haguenoer, Sengchanh, Gaudy-Graffin (ref115) 2014; 111 Arbyn, Fabri, Temmerman, Simoens (ref17) 2014; 9 Stanczuk, Baxter, Currie (ref128) 2017; 26 Seo, Song, Kim, Park, Kang, Lee (ref83) 2006; 102 Qiao, Sellors, Eder (ref85) 2008; 9 Belinson, Du, Yang (ref91) 2012; 130 Virtanen, Nieminen, Luostarinen, Anttila (ref108) 2011; 20 Darlin, Borgfeldt, Forslund, Hénic, Dillner, Kannisto (ref96) 2013; 56 Cadman, Wilkes, Mansour (ref114) 2015; 22 Arrossi, Thouyaret, Herrero (ref116) 2015; 3 Verdoodt, Jentschke, Hillemanns, Racey, Snijders, Arbyn (ref23) 2015; 51 Zhao, Lewkowitz, Chen (ref95) 2012; 104 Twu, Yen, Lau, Chen, Yu, Lin (ref90) 2011; 156 Lam, Rebolj, Møller Ejegod (ref126) 2017; 140 McLachlan, Anderson, Hawkes, Saville, Arabena (ref130) 2018; 25 Jentschke, Chen, Arbyn (ref53) 2016; 82 Szarewski, Cadman, Mallett (ref84) 2007; 14 Van Keer, Tjalma, Pattyn (ref124) 2018; 37 Dijkstra, Heideman, van Kemenade (ref92) 2012; 54 Gustavsson, Aarnio, Berggrund (ref131) 2018; 118 Arbyn, Raifu, Weiderpass, Bray, Anttila (ref4) 2009; 45 Racey, Withrow, Gesink (ref24) 2013; 104 Morrison, Goldberg, Hagan, Kadish, Burk (ref70) 1992; 167 Pathak, Dodds, Zamora, Khan (ref123) 2014; 349 Enerly, Bonde, Schee, Pedersen, Lönnberg, Nygård (ref62) 2016; 11 Arbyn, Verdoodt, Snijders (ref22) 2014; 15 Whiting, Rutjes, Westwood (ref29) 2011; 155 Chernesky, Jang, Gilchrist (ref44) 2014; 41 Leinonen, Schee, Jonassen (ref61) 2018; 99-100 Bais, van Kemenade, Berkhof (ref102) 2007; 120 Laukkanen, Koskela, Pukkala (ref13) 2003; 84 Gök, van Kemenade, Heideman (ref110) 2012; 130 Sanner, Wikström, Strand, Lindell, Wilander (ref125) 2009; 101 Salmerón, Lazcano-Ponce, Lorincz (ref78) 2003; 14 Harbord, Deeks, Egger, Whiting, Sterne (ref33) 2007; 8 Daponte, Pournaras, Mademtzis (ref80) 2006; 103 Higgins, Thompson, Deeks, Altman (ref39) 2003; 327 Tranberg, Bech, Blaakær, Jensen, Svanholm, Andersen (ref26) 2018; 18 Belinson, Qiao, Pretorius (ref74) 2001; 83 Asciutto, Henningsson, Borgfeldt, Darlin, Borgfeldt (ref57) 2017; 37 Asciutto, Ernstson, Forslund, Borgfeldt (ref60) 2018; 101 Wang, Hu, Chen (ref47) 2014; 15 Elit, Saskin, Raut, Elliott, Murphy, Marrett (ref15) 2013; 128 van Baars, Bosgraaf, ter Harmsel, Melchers, Quint, Bekkers (ref94) 2012; 50 Arbyn, Ronco, Anttila (ref18) 2012; 30 Stanczuk, Baxter, Currie (ref55) 2016; 6 Broberg, Gyrd-Hansen, Miao Jonasson (ref113) 2014; 134 Nobbenhuis, Helmerhorst, van den Brule (ref76) 2002; 55 Zehbe, Jackson, Wood (ref66) 2016; 6 Gustavsson, Sanner, Lindell (ref88) 2011; 51 Leeman, Del Pino, Molijn (ref59) 2017; 124 Schee, Stefan, Pedersen, Bonde, Nyganullrd (ref118) 2014; 74(Suppl 19) Hillemanns, Kimmig, Hüttemann, Dannecker, Thaler (ref71) 1999; 354 Qin, Zhang, Marlowe (ref54) 2016; 85 Guan, Gravitt, Howard (ref98) 2013; 189 Deeks, Macaskill, Irwig (ref36) 2005; 58 Porras, Hildesheim, Gonzalez (ref50) 2014; 107 Saville, Hawkes, Mclachlan, Anderson, Arabena (ref129) 2018; 25 Modibbo, Iregbu, Okuma (ref68) 2017; 12 Holanda, Castelo, Veras, de Almeida, Lins, Dores (ref82) 2006; 95 Harbord, Whiting (ref34) 2009; 9 Moher, Liberati, Tetzlaff, Altman (ref31) 2009; 151 Catarino, Vassilakos, Bilancioni (ref58) 2017; 12 Giorgi Rossi, Fortunato, Barbarino (ref117) 2015; 112 Bhatla, Dar, Patro (ref86) 2009; 33 Baussano, Tshering, Choden (ref127) 2017; 7 Snijders, Verhoef, Arbyn (ref21) 2013; 132 Zhao, Jeronimo, Qiao (ref43) 2013; 6 Snellenberg, De Strooper, Hesselink (ref120) 2012; 12 Kitchener, Gittins, Cruickshank (ref67) 2018; 25 DerSimonian, Laird (ref41) 1986; 7 Boggan, Walmer, Henderson (ref49) 2015; 42 Ricardo-Rodrigues, Jiménez-García, Hernández-Barrera, Carrasco-Garrido, Jiménez-Trujillo, López de Andrés (ref16) 2015; 129 Lorenzato, Singer, Ho (ref75) 2002; 186 Kellen, Benoy, Vanden Broeck (ref69) 2018; 143 Arbyn, Peeters, Benoy (ref119) 2018; 107 Longatto-Filho, Naud, Derchain (ref93) 2012; 460 Gök, Heideman, van Kemenade (ref103) 2010; 340 Wikström, Lindell, Sanner, Wilander (ref109) 2011; 105 Jentschke, Lange, Soergel, Hillemanns (ref100) 2013; 92 Higgins, Altman, Gøtzsche (ref30) 2011; 343 Nieves, Enerson, Belinson (ref101) 2013; 23 Geraets, van Baars, Alonso (ref97) 2013; 57 Balasubramanian, Kulasingam, Baer (ref87) 2010; 14 Aiko, Yoko, Saito (ref56) 2017; 43 Garcia, Barker, Santos (ref77) 2003; 102 Girianelli, Thuler, Szklo (ref81) 2006; 15 Hesselink, Berkhof, van der Salm (ref45) 2014; 52 Moses, Pedersen, Mitchell (ref63) 2015; 20 Arbyn, Castellsagué, de Sanjosé (ref1) 2011; 22 Sellors, Lorincz, Mahony (ref72) 2000; 163 Bray, Loos, McCarron (ref3) 2005; 14 Sultana, English, Simpson (ref65) 2016; 139 Taylor, Wang, Wright, Denny, Kuhn (ref89) 2011; 129 Harbord, Harris, Sterne (ref37) 2009; 9 Wright, Denny, Kuhn, Pollack, Lorincz (ref73) 2000; 283 Zhang, Kang, Liu (ref48) 2014; 36 Giorgi Rossi, Marsili, Camilloni (ref104) 2011; 104 Arbyn, Antoine, Mägi (ref5) 2011; 128 Curry, Krist, Owens (ref25) 2018; 320 Lehtinen, Kaasila, Pasanen (ref14) 2006; 119 Piana, Leandri, Le, Heid, Tamalet, Sancho-Garnier (ref106) 2011; 98 Lazcano-Ponce, Lorincz, Cruz-Valdez (ref105) 2011; 378 Arbyn, Snijders, Meijer (ref28) 2015; 21 Szarewski, Cadman, Mesher (ref107) 2011; 104 Cuschieri, Ronco, Lorincz (ref121) 2018; 143 Harbord, Higgins (ref42) 2013; 8 Jeronimo, Bansil, Lim (ref46) 2014; 24 Darlin, Borgfeldt, Forslund (ref111) 2013; 58 Jentschke, Soergel, Hillemanns (ref99) 2013; 193 key20190314145725_ref69 key20190314145725_ref68 key20190314145725_ref67 key20190314145725_ref62 key20190314145725_ref61 key20190314145725_ref60 key20190314145725_ref66 key20190314145725_ref65 key20190314145725_ref64 key20190314145725_ref63 key20190314145725_ref79 Garcia (key20190314145725_ref77) 2003; 102 key20190314145725_ref78 key20190314145725_ref73 key20190314145725_ref71 key20190314145725_ref70 key20190314145725_ref76 key20190314145725_ref75 key20190314145725_ref74 key20190314145725_ref80 key20190314145725_ref116 key20190314145725_ref47 key20190314145725_ref115 key20190314145725_ref46 key20190314145725_ref114 key20190314145725_ref45 key20190314145725_ref113 Harbord (key20190314145725_ref37) 2009; 9 key20190314145725_ref111 key20190314145725_ref110 key20190314145725_ref49 key20190314145725_ref44 key20190314145725_ref43 Deeks (key20190314145725_ref32) 2013 key20190314145725_ref41 Harris (key20190314145725_ref40) 2008; 8 Harbord (key20190314145725_ref34) 2009; 9 key20190314145725_ref119 key20190314145725_ref118 key20190314145725_ref117 key20190314145725_ref59 key20190314145725_ref105 key20190314145725_ref58 key20190314145725_ref104 key20190314145725_ref103 key20190314145725_ref56 key20190314145725_ref102 key20190314145725_ref101 key20190314145725_ref100 Harbord (key20190314145725_ref42) 2013; 8 key20190314145725_ref51 key20190314145725_ref50 key20190314145725_ref55 key20190314145725_ref54 key20190314145725_ref53 key20190314145725_ref52 Asciutto (key20190314145725_ref57) 2017; 37 key20190314145725_ref109 key20190314145725_ref108 key20190314145725_ref107 key20190314145725_ref26 key20190314145725_ref25 key20190314145725_ref23 key20190314145725_ref29 key20190314145725_ref28 key20190314145725_ref132 key20190314145725_ref131 key20190314145725_ref130 key20190314145725_ref22 key20190314145725_ref21 key20190314145725_ref20 IARC (key20190314145725_ref7) 2005 key20190314145725_ref4 key20190314145725_ref127 key20190314145725_ref3 key20190314145725_ref36 key20190314145725_ref126 key20190314145725_ref6 key20190314145725_ref35 key20190314145725_ref125 key20190314145725_ref5 key20190314145725_ref124 key20190314145725_ref123 key20190314145725_ref122 key20190314145725_ref2 key20190314145725_ref39 key20190314145725_ref121 key20190314145725_ref1 key20190314145725_ref38 key20190314145725_ref120 key20190314145725_ref33 key20190314145725_ref30 key20190314145725_ref8 key20190314145725_ref129 key20190314145725_ref9 key20190314145725_ref128 key20190314145725_ref89 key20190314145725_ref84 key20190314145725_ref83 key20190314145725_ref82 key20190314145725_ref81 key20190314145725_ref88 key20190314145725_ref87 key20190314145725_ref86 key20190314145725_ref85 key20190314145725_ref91 key20190314145725_ref90 Sancho-Garnier (key20190314145725_ref112) 2013; 133 Racey (key20190314145725_ref24) 2013; 104 key20190314145725_ref15 key20190314145725_ref14 key20190314145725_ref13 Zhang (key20190314145725_ref48) 2014; 36 key20190314145725_ref12 key20190314145725_ref18 key20190314145725_ref17 key20190314145725_ref16 key20190314145725_ref95 key20190314145725_ref94 key20190314145725_ref93 key20190314145725_ref92 key20190314145725_ref11 Chao (key20190314145725_ref27) 2018 key20190314145725_ref99 key20190314145725_ref10 key20190314145725_ref98 key20190314145725_ref97 key20190314145725_ref96 Moher (key20190314145725_ref31) 2009; 151 Piana (key20190314145725_ref106) 2011; 98 Koliopoulos (key20190314145725_ref19) 2017; 8 Sellors (key20190314145725_ref72) 2000; 163 |
| References_xml | – volume: 104 start-page: e159 year: 2013 ident: ref24 article-title: Self-collected HPV Testing Improves Participation in Cervical Cancer Screening: A Systematic Review and Meta-analysis publication-title: Can.J.Public Health – volume: 112 start-page: 667 year: 2015 ident: ref117 article-title: Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter publication-title: Br J Cancer – volume: 383 start-page: 524 year: 2014 ident: ref20 article-title: Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials publication-title: Lancet – volume: 33 start-page: 2005 year: 2014 ident: ref122 article-title: Optimization of HPV DNA detection in urine by improving collection, storage, and extraction publication-title: Eur J Clin Microbiol Infect Dis – volume: 129 start-page: 879 year: 2011 ident: ref89 article-title: A comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treat publication-title: Int J Cancer – volume: 15 start-page: 504 year: 2006 ident: ref81 article-title: Comparison of human papillomavirus DNA tests, liquid-based cytology and conventional cytology for the early detection of cervix uteri cancer publication-title: Eur J Cancer Prev – volume: 14 start-page: 34 year: 2007 ident: ref84 article-title: Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting publication-title: J Med Screen – volume: 52 start-page: 890 year: 2014 ident: ref45 article-title: Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region publication-title: J Clin Microbiol – volume: 167 start-page: 104 year: 1992 ident: ref70 article-title: Self-administered home cervicovaginal lavage: a novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections publication-title: Am J Obstet Gynecol – volume: 156 start-page: 96 year: 2011 ident: ref90 article-title: Type-specific human papillomavirus DNA testing with the genotyping array: a comparison of cervical and vaginal sampling publication-title: Eur J Obstet Gynecol Reprod Biol – volume: 20 start-page: 1960 year: 2011 ident: ref108 article-title: Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial publication-title: Cancer Epidemiol Biomarkers Prev – volume: 101 start-page: 871 year: 2009 ident: ref125 article-title: Self-sampling of the vaginal fluid at home combined with high-risk HPV testing publication-title: Br J Cancer – volume: 132 start-page: 2223 year: 2013 ident: ref21 article-title: High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening publication-title: Int J Cancer – volume: 36 start-page: 389 year: 2014 ident: ref48 article-title: [Evaluation of screening performance of HPV DNA test on specimens from different sites of the female genital tract] publication-title: Zhonghua Zhong Liu Za Zhi – volume: 128 start-page: 95 year: 2013 ident: ref15 article-title: Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort publication-title: Gynecol Oncol – volume: 7 start-page: 177 year: 1986 ident: ref41 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials – volume: 12 start-page: 551 year: 2012 ident: ref120 article-title: Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape publication-title: BMC Cancer – volume: 15 start-page: 172 year: 2014 ident: ref22 article-title: Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis publication-title: Lancet Oncol – volume: 102 start-page: 67 year: 2006 ident: ref83 article-title: Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray publication-title: Gynecol Oncol – volume: 8 start-page: 239 year: 2007 ident: ref33 article-title: A unification of models for meta-analysis of diagnostic accuracy studies publication-title: Biostatistics – volume: 283 start-page: 81 year: 2000 ident: ref73 article-title: HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer publication-title: JAMA – volume: 140 start-page: 2212 year: 2017 ident: ref126 article-title: Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms publication-title: Int J Cancer – volume: 378 start-page: 1868 year: 2011 ident: ref105 article-title: Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial publication-title: Lancet – volume: 98 start-page: 723 year: 2011 ident: ref106 article-title: L’auto-prélèvement vaginal à domicile pour recherche de papilloma virus à haut risque. Une solution de remplacement pour les femmes ne participant pas au dépistage cytologique des cancers du col de l’utérus. Campagne expérimentale du département des Bouches-du-Rhône publication-title: Bull Cancer – volume: 55 start-page: 435 year: 2002 ident: ref76 article-title: Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women publication-title: J Clin Pathol – volume: 14 start-page: 185 year: 2010 ident: ref87 article-title: Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples publication-title: J Low Genit Tract Dis – volume: 12 start-page: 11 year: 2017 ident: ref68 article-title: Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria publication-title: Infect Agent Cancer – volume: 163 start-page: 513 year: 2000 ident: ref72 article-title: Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions publication-title: CMAJ – volume: 104 start-page: 178 year: 2012 ident: ref95 article-title: Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method publication-title: J Natl Cancer Inst – volume: 7 start-page: e016309 year: 2017 ident: ref127 article-title: Cervical cancer screening in rural Bhutan with the careHPV test on self-collected samples: an ongoing cross-sectional, population-based study (REACH-Bhutan) publication-title: BMJ Open – volume: 50 start-page: 3937 year: 2012 ident: ref94 article-title: Dry storage and transport of a cervicovaginal self-sample using the Evalyn Brush(R): reliable HPV detection combined with women’s comfort publication-title: J Clin Microbiol – volume: 84 start-page: 2105 year: 2003 ident: ref13 article-title: Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland publication-title: J Gen Virol – volume: 130 start-page: 1855 year: 2012 ident: ref91 article-title: Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing publication-title: Int J Cancer – volume: 31 start-page: H32 year: 2013 ident: ref6 article-title: Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia publication-title: Vaccine – volume: 21 start-page: 817 year: 2015 ident: ref28 article-title: Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? publication-title: Clin Microbiol Infect – volume: 327 start-page: 557 year: 2003 ident: ref39 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ – volume: 155 start-page: 529 year: 2011 ident: ref29 article-title: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies publication-title: Ann Intern Med – volume: 340 start-page: c1040 year: 2010 ident: ref103 article-title: HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study publication-title: BMJ – volume: 58 start-page: 155 year: 2013 ident: ref111 article-title: Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening publication-title: J Clin Virol – volume: 99-100 start-page: 22 year: 2018 ident: ref61 article-title: Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions publication-title: J Clin Virol – volume: 95 start-page: 179 year: 2006 ident: ref82 article-title: Primary screening for cervical cancer through self sampling publication-title: Int J Gynaecol Obstet – volume: 104 start-page: 248 year: 2011 ident: ref104 article-title: The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600) publication-title: Br J Cancer – volume: 51 start-page: 255 year: 2011 ident: ref88 article-title: Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge publication-title: J Clin Virol – volume: 128 start-page: 1899 year: 2011 ident: ref5 article-title: Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania publication-title: Int J Cancer – volume: 11 start-page: e0151978 year: 2016 ident: ref62 article-title: Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme publication-title: PLoS One – volume: 19 start-page: 127 year: 2012 ident: ref8 article-title: Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24 publication-title: J Med Screen – volume: 22 start-page: 2675 year: 2011 ident: ref1 article-title: Worldwide burden of cervical cancer in 2008 publication-title: Ann Oncol – volume: 54 start-page: 147 year: 2012 ident: ref92 article-title: Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN publication-title: J Clin Virol – volume: 119 start-page: 2612 year: 2006 ident: ref14 article-title: Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s publication-title: Int J Cancer – volume: 58 start-page: 882 year: 2005 ident: ref36 article-title: The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed publication-title: J Clin Epidemiol – volume: 30 start-page: F88 year: 2012 ident: ref18 article-title: Evidence regarding HPV testing in secondary prevention of cervical cancer publication-title: Vaccine – volume: 42 start-page: 1839 year: 2016 ident: ref52 article-title: Excellent analytical and clinical performance of a dry self-sampling device for human papillomavirus detection in an urban Chinese referral population publication-title: J Obstet Gynaecol Res – volume: 189 start-page: 167 year: 2013 ident: ref98 article-title: Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens publication-title: J Virol Methods – volume: 41 start-page: 365 year: 2014 ident: ref44 article-title: Evaluation of a new APTIMA specimen collection and transportation kit for high-risk human papillomavirus E6/E7 messenger RNA in cervical and vaginal samples publication-title: Sex Transm Dis – volume: 343 start-page: d5928 year: 2011 ident: ref30 article-title: The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials publication-title: BMJ – volume: 15 year: 2016 ident: ref51 article-title: Evaluation of novel assays for the detection of human papilloma virus in self-collected samples for cervical cancer screening publication-title: Genet Mol Res – volume: 25 start-page: 88 year: 2018 ident: ref67 article-title: A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial publication-title: J Med Screen – volume: 6 start-page: 938 year: 2013 ident: ref43 article-title: An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China publication-title: Cancer Prev Res (Phila) – volume: 23 start-page: 513 year: 2013 ident: ref101 article-title: Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection publication-title: Int J Gynecol Cancer – volume: 24 start-page: 576 year: 2014 ident: ref46 article-title: A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer publication-title: Int J Gynecol Cancer – volume: 101 start-page: 69 year: 2018 ident: ref60 article-title: Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples publication-title: J Clin Virol – volume: 33 start-page: 446 year: 2009 ident: ref86 article-title: Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? publication-title: Cancer Epidemiol – volume: 15 start-page: 7085 year: 2014 ident: ref47 article-title: Clinical evaluation of human papillomavirus detection by careHPV™ test on physician-samples and self-samples using the indicating FTA Elute® card publication-title: Asian Pac J Cancer Prev – volume: 133 start-page: 2681 year: 2013 ident: ref112 article-title: HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France publication-title: Int J Cancer – volume: 143 start-page: 735 year: 2018 ident: ref121 article-title: Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs publication-title: Int J Cancer – volume: 51 start-page: 2375 year: 2015 ident: ref23 article-title: Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials publication-title: Eur J Cancer – volume: 14 start-page: 505 year: 2003 ident: ref78 article-title: Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico publication-title: Cancer Causes Control – volume: 460 start-page: 577 year: 2012 ident: ref93 article-title: Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology publication-title: Virchows Arch – volume: 107 start-page: 400 year: 2014 ident: ref50 article-title: Performance of Self-Collected Cervical Samples in Screening for Future Precancer Using Human Papillomavirus DNA Testing publication-title: J Natl Cancer Inst – volume: 102 start-page: 266 year: 2003 ident: ref77 article-title: Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus publication-title: Obstet Gynecol – volume: 25 start-page: 17 year: 2018 ident: ref130 article-title: Completing the cervical screening pathway: Factors that facilitate the increase of self-collection uptake among under-screened and never-screened women, an Australian pilot study publication-title: Curr Oncol – volume: 85 start-page: 80 year: 2016 ident: ref54 article-title: Evaluation of human papillomavirus detection by Abbott m2000 system on samples collected by FTA Elute™ Card in a Chinese HIV-1 positive population publication-title: J Clin Virol – volume: 74(Suppl 19) start-page: 4135 year: 2014 ident: ref118 article-title: Improving attendance to the cervical cancer screening program: Does self-sampling at home improve cervical cancer prevention publication-title: Cancer Res – volume: 129 start-page: 881 year: 2015 ident: ref16 article-title: Social disparities in access to breast and cervical cancer screening by women living in Spain publication-title: Public Health – volume: 8 start-page: 493 year: 2013 ident: ref42 article-title: Meta-regression in Stata publication-title: Stata J – volume: 8 start-page: CD008587 year: 2017 ident: ref19 article-title: Cytology versus HPV testing for cervical cancer screening in the general population publication-title: Cochrane Database Syst Rev – volume: 22 start-page: 28 year: 2015 ident: ref114 article-title: A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening publication-title: J Med Screen – volume: 139 start-page: 281 year: 2016 ident: ref65 article-title: Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia publication-title: Int J Cancer – volume: 9 start-page: 929 year: 2008 ident: ref85 article-title: A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China publication-title: Lancet Oncol – volume: 105 start-page: 337 year: 2011 ident: ref109 article-title: Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study publication-title: Br J Cancer – volume: 83 start-page: 439 year: 2001 ident: ref74 article-title: Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia publication-title: Gynecol Oncol – volume: 111 start-page: 2187 year: 2014 ident: ref115 article-title: Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial publication-title: Br J Cancer – volume: 25 start-page: 489 year: 2016 ident: ref64 article-title: Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability publication-title: J Womens Health (Larchmt) – volume: 104 start-page: 915 year: 2011 ident: ref107 article-title: HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial publication-title: Br J Cancer – volume: 82 start-page: 46 year: 2016 ident: ref53 article-title: Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections publication-title: J Clin Virol – volume: 124 start-page: 1356 year: 2017 ident: ref59 article-title: HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population publication-title: BJOG – volume: 9 start-page: e92615 year: 2014 ident: ref17 article-title: Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006) publication-title: PLoS One – volume: 107 start-page: 52 year: 2018 ident: ref119 article-title: VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples publication-title: J Clin Virol – volume: 45 start-page: 2640 year: 2009 ident: ref4 article-title: Trends of cervical cancer mortality in the member states of the European Union publication-title: Eur J Cancer – volume: 20 start-page: 1355 year: 2015 ident: ref63 article-title: Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial publication-title: Trop Med Int Health – volume: 26 start-page: 1629 year: 2017 ident: ref128 article-title: Defining optimal triage strategies for hrHPV screen positive women - an evaluation of HPV 16/18 genotyping, cytology and p16/Ki-67 cyto-immunochemistry publication-title: Cancer Epidemiol Biomarkers Prev – volume: 118 start-page: 896 year: 2018 ident: ref131 article-title: Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology publication-title: Br J Cancer – volume: 12 start-page: e0181905 year: 2017 ident: ref58 article-title: Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay publication-title: PLoS One – volume: 6 start-page: e011754 year: 2016 ident: ref66 article-title: Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology publication-title: BMJ Open – volume: 349 start-page: g5264 year: 2014 ident: ref123 article-title: Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis publication-title: BMJ – volume: 37 start-page: 4183 year: 2017 ident: ref57 article-title: Vaginal and Urine Self-sampling Compared to Cervical Sampling for HPV-testing with the Cobas 4800 HPV Test publication-title: Anticancer Res – volume: 72 start-page: 39 year: 2014 ident: ref38 article-title: Metaprop: a Stata command to perform meta-analysis of binomial data publication-title: Arch Public Health – volume: 3 start-page: e85 year: 2015 ident: ref116 article-title: Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial publication-title: Lancet Glob Health – volume: 186 start-page: 962 year: 2002 ident: ref75 article-title: Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples publication-title: Am J Obstet Gynecol – volume: 92 start-page: 160 year: 2013 ident: ref100 article-title: Enzyme-linked immunosorbent assay for p16(INK4a) - a new triage test for the detection of cervical intraepithelial neoplasia? publication-title: Acta Obstet Gynecol Scand – volume: 354 start-page: 1970 year: 1999 ident: ref71 article-title: Screening for cervical neoplasia by self-assessment for human papillomavirus DNA publication-title: Lancet – volume: 193 start-page: 131 year: 2013 ident: ref99 article-title: Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples publication-title: J Virol Methods – volume: 57 start-page: 125 year: 2013 ident: ref97 article-title: Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge publication-title: J Clin Virol – volume: 43 start-page: 710 year: 2017 ident: ref56 article-title: Accuracy of self-collected human papillomavirus samples from Japanese women with abnormal cervical cytology publication-title: J Obstet Gynaecol Res – volume: 14 start-page: 677 year: 2005 ident: ref3 article-title: Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening publication-title: Cancer Epidemiol Biomarkers Prev – volume: 130 start-page: 1128 year: 2012 ident: ref110 article-title: Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program publication-title: Int J Cancer – volume: 120 start-page: 1505 year: 2007 ident: ref102 article-title: Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs publication-title: Int J Cancer – volume: 320 start-page: 674 year: 2018 ident: ref25 article-title: Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement publication-title: JAMA – volume: 8 start-page: 3 year: 2008 ident: ref40 article-title: metan: fixed- and random-effects meta-analysis publication-title: Stata J – volume: 103 start-page: 463 year: 2006 ident: ref80 article-title: Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy publication-title: Gynecol Oncol – volume: 143 start-page: 861 year: 2018 ident: ref69 article-title: A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program publication-title: Int J Cancer – volume: 26 start-page: 1105 year: 2015 ident: ref9 article-title: Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012 publication-title: Cancer Causes Control – volume: 151 start-page: 264 year: 2009 ident: ref31 article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: Ann Intern Med – volume: 42 start-page: 655 year: 2015 ident: ref49 article-title: Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population publication-title: Sex Transm Dis – volume: 25 start-page: 27 year: 2018 ident: ref129 article-title: Self-collection for under-screened women in a National Cervical Screening Program: pilot study publication-title: Curr Oncol – volume: 9 start-page: 197 year: 2009 ident: ref37 article-title: Updated tests for small-study effects in meta-analyses publication-title: Stata J – volume: 44 start-page: 2518 year: 2006 ident: ref79 article-title: High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush publication-title: J Clin Microbiol – volume: 37 start-page: 859 year: 2018 ident: ref124 article-title: Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples publication-title: Eur J Clin Microbiol Infect Dis – volume: 9 start-page: 211 year: 2009 ident: ref34 article-title: metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression publication-title: Stata J – volume: 56 start-page: 52 year: 2013 ident: ref96 article-title: Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity publication-title: J Clin Virol – volume: 18 start-page: 273 year: 2018 ident: ref26 article-title: Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial publication-title: BMC Cancer – volume: 6 start-page: e010660 year: 2016 ident: ref55 article-title: Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study) publication-title: BMJ Open – volume: 134 start-page: 2223 year: 2014 ident: ref113 article-title: Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial publication-title: Int J Cancer – ident: key20190314145725_ref90 doi: 10.1016/j.ejogrb.2010.12.023 – ident: key20190314145725_ref80 doi: 10.1016/j.ygyno.2006.03.021 – ident: key20190314145725_ref84 doi: 10.1258/096914107780154486 – ident: key20190314145725_ref105 doi: 10.1016/S0140-6736(11)61522-5 – ident: key20190314145725_ref127 doi: 10.1136/bmjopen-2017-016309 – ident: key20190314145725_ref13 doi: 10.1099/vir.0.18995-0 – ident: key20190314145725_ref92 doi: 10.1016/j.jcv.2012.02.022 – ident: key20190314145725_ref103 doi: 10.1136/bmj.c1040 – volume: 8 start-page: 493 year: 2013 ident: key20190314145725_ref42 article-title: Meta-regression in Stata publication-title: Stata J doi: 10.1177/1536867X0800800403 – volume: 36 start-page: 389 year: 2014 ident: key20190314145725_ref48 article-title: [Evaluation of screening performance of HPV DNA test on specimens from different sites of the female genital tract] publication-title: Zhonghua Zhong Liu Za Zhi – ident: key20190314145725_ref126 doi: 10.1002/ijc.30647 – ident: key20190314145725_ref123 doi: 10.1136/bmj.g5264 – ident: key20190314145725_ref3 doi: 10.1158/1055-9965.EPI-04-0569 – volume-title: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. year: 2013 ident: key20190314145725_ref32 – ident: key20190314145725_ref102 doi: 10.1002/ijc.22484 – ident: key20190314145725_ref71 doi: 10.1016/S0140-6736(99)04110-0 – volume: 8 start-page: CD008587 year: 2017 ident: key20190314145725_ref19 article-title: Cytology versus HPV testing for cervical cancer screening in the general population publication-title: Cochrane Database Syst Rev – ident: key20190314145725_ref46 doi: 10.1097/IGC.0000000000000084 – ident: key20190314145725_ref38 doi: 10.1186/2049-3258-72-39 – ident: key20190314145725_ref45 doi: 10.1128/JCM.03195-13 – ident: key20190314145725_ref108 doi: 10.1158/1055-9965.EPI-11-0307 – ident: key20190314145725_ref118 doi: 10.1158/1538-7445.AM2014-4135 – ident: key20190314145725_ref39 doi: 10.1136/bmj.327.7414.557 – ident: key20190314145725_ref111 doi: 10.1016/j.jcv.2013.06.029 – ident: key20190314145725_ref129 doi: 10.3747/co.25.3915 – ident: key20190314145725_ref21 doi: 10.1002/ijc.27790 – ident: key20190314145725_ref6 doi: 10.1016/j.vaccine.2013.02.071 – ident: key20190314145725_ref18 doi: 10.1016/j.vaccine.2012.06.095 – ident: key20190314145725_ref70 doi: 10.1016/S0002-9378(11)91637-8 – volume: 9 start-page: 197 year: 2009 ident: key20190314145725_ref37 article-title: Updated tests for small-study effects in meta-analyses publication-title: Stata J doi: 10.1177/1536867X0900900202 – ident: key20190314145725_ref119 doi: 10.1016/j.jcv.2018.08.006 – ident: key20190314145725_ref10 – ident: key20190314145725_ref62 doi: 10.1371/journal.pone.0151978 – ident: key20190314145725_ref54 doi: 10.1016/j.jcv.2016.11.002 – ident: key20190314145725_ref9 doi: 10.1007/s10552-015-0603-7 – ident: key20190314145725_ref47 doi: 10.7314/APJCP.2014.15.17.7085 – ident: key20190314145725_ref73 doi: 10.1001/jama.283.1.81 – ident: key20190314145725_ref83 doi: 10.1016/j.ygyno.2005.11.030 – ident: key20190314145725_ref101 doi: 10.1097/IGC.0b013e318280f3bc – ident: key20190314145725_ref122 doi: 10.1007/s10096-014-2147-2 – ident: key20190314145725_ref115 doi: 10.1038/bjc.2014.510 – ident: key20190314145725_ref36 doi: 10.1016/j.jclinepi.2005.01.016 – ident: key20190314145725_ref104 doi: 10.1038/sj.bjc.6606040 – volume: 163 start-page: 513 year: 2000 ident: key20190314145725_ref72 article-title: Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions publication-title: CMAJ – ident: key20190314145725_ref61 doi: 10.1016/j.jcv.2017.12.008 – ident: key20190314145725_ref25 doi: 10.1001/jama.2018.10897 – ident: key20190314145725_ref53 doi: 10.1016/j.jcv.2016.06.016 – ident: key20190314145725_ref82 doi: 10.1016/j.ijgo.2006.07.012 – ident: key20190314145725_ref8 doi: 10.1258/jms.2012.012081 – volume: 104 start-page: e159 year: 2013 ident: key20190314145725_ref24 article-title: Self-collected HPV Testing Improves Participation in Cervical Cancer Screening: A Systematic Review and Meta-analysis publication-title: Can.J.Public Health doi: 10.1007/BF03405681 – volume: 37 start-page: 4183 year: 2017 ident: key20190314145725_ref57 article-title: Vaginal and Urine Self-sampling Compared to Cervical Sampling for HPV-testing with the Cobas 4800 HPV Test publication-title: Anticancer Res – ident: key20190314145725_ref11 – ident: key20190314145725_ref66 doi: 10.1136/bmjopen-2016-011754 – ident: key20190314145725_ref86 doi: 10.1016/j.canep.2009.10.013 – ident: key20190314145725_ref130 doi: 10.3747/co.25.3916 – ident: key20190314145725_ref76 doi: 10.1136/jcp.55.6.435 – ident: key20190314145725_ref20 doi: 10.1016/S0140-6736(13)62218-7 – ident: key20190314145725_ref69 doi: 10.1002/ijc.31391 – ident: key20190314145725_ref128 doi: 10.1158/1055-9965.EPI-17-0534 – ident: key20190314145725_ref17 doi: 10.1371/journal.pone.0092615 – volume: 98 start-page: 723 year: 2011 ident: key20190314145725_ref106 article-title: L’auto-prélèvement vaginal à domicile pour recherche de papilloma virus à haut risque. Une solution de remplacement pour les femmes ne participant pas au dépistage cytologique des cancers du col de l’utérus. Campagne expérimentale du département des Bouches-du-Rhône publication-title: Bull Cancer doi: 10.1684/bdc.2011.1388 – ident: key20190314145725_ref52 doi: 10.1111/jog.13132 – volume-title: HPV Self-Sampling for Primary Cervical Cancer Screening: A Review of Diagnostic Test Accuracy and Clinical Evidence year: 2018 ident: key20190314145725_ref27 – ident: key20190314145725_ref107 doi: 10.1038/bjc.2011.48 – ident: key20190314145725_ref124 doi: 10.1007/s10096-017-3179-1 – ident: key20190314145725_ref67 doi: 10.1177/0969141317696518 – volume: 102 start-page: 266 year: 2003 ident: key20190314145725_ref77 article-title: Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus publication-title: Obstet Gynecol – ident: key20190314145725_ref49 doi: 10.1097/OLQ.0000000000000345 – ident: key20190314145725_ref30 doi: 10.1136/bmj.d5928 – ident: key20190314145725_ref58 doi: 10.1371/journal.pone.0181905 – ident: key20190314145725_ref121 doi: 10.1002/ijc.31261 – ident: key20190314145725_ref43 doi: 10.1158/1940-6207.CAPR-13-0091 – ident: key20190314145725_ref91 doi: 10.1002/ijc.26202 – ident: key20190314145725_ref99 doi: 10.1016/j.jviromet.2013.05.009 – ident: key20190314145725_ref44 doi: 10.1097/OLQ.0000000000000125 – ident: key20190314145725_ref95 doi: 10.1093/jnci/djr532 – ident: key20190314145725_ref33 doi: 10.1093/biostatistics/kxl004 – ident: key20190314145725_ref81 doi: 10.1097/01.cej.0000220630.08352.7a – ident: key20190314145725_ref55 doi: 10.1136/bmjopen-2015-010660 – ident: key20190314145725_ref60 doi: 10.1016/j.jcv.2018.02.002 – ident: key20190314145725_ref110 doi: 10.1002/ijc.26128 – ident: key20190314145725_ref22 doi: 10.1016/S1470-2045(13)70570-9 – ident: key20190314145725_ref97 doi: 10.1016/j.jcv.2013.02.016 – ident: key20190314145725_ref116 doi: 10.1016/S2214-109X(14)70354-7 – ident: key20190314145725_ref94 doi: 10.1128/JCM.01506-12 – ident: key20190314145725_ref51 doi: 10.4238/gmr.15027896 – ident: key20190314145725_ref16 doi: 10.1016/j.puhe.2015.02.021 – volume: 9 start-page: 211 year: 2009 ident: key20190314145725_ref34 article-title: metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression publication-title: Stata J doi: 10.1177/1536867X0900900203 – ident: key20190314145725_ref41 doi: 10.1016/0197-2456(86)90046-2 – volume: 8 start-page: 3 year: 2008 ident: key20190314145725_ref40 article-title: metan: fixed- and random-effects meta-analysis publication-title: Stata J doi: 10.1177/1536867X0800800102 – ident: key20190314145725_ref98 doi: 10.1016/j.jviromet.2012.11.010 – ident: key20190314145725_ref64 doi: 10.1089/jwh.2015.5348 – ident: key20190314145725_ref75 doi: 10.1067/mob.2002.122390 – ident: key20190314145725_ref100 doi: 10.1111/aogs.12032 – volume-title: Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10 year: 2005 ident: key20190314145725_ref7 – ident: key20190314145725_ref88 doi: 10.1016/j.jcv.2011.05.006 – ident: key20190314145725_ref78 doi: 10.1023/A:1024806707399 – ident: key20190314145725_ref120 doi: 10.1186/1471-2407-12-551 – ident: key20190314145725_ref74 doi: 10.1006/gyno.2001.6370 – ident: key20190314145725_ref85 doi: 10.1016/S1470-2045(08)70210-9 – ident: key20190314145725_ref87 doi: 10.1097/LGT.0b013e3181cd6d36 – ident: key20190314145725_ref15 doi: 10.1016/j.ygyno.2012.10.006 – ident: key20190314145725_ref35 – ident: key20190314145725_ref109 doi: 10.1038/bjc.2011.236 – ident: key20190314145725_ref113 doi: 10.1002/ijc.28545 – ident: key20190314145725_ref93 doi: 10.1007/s00428-012-1242-y – ident: key20190314145725_ref96 doi: 10.1016/j.jcv.2012.09.002 – ident: key20190314145725_ref2 – ident: key20190314145725_ref23 doi: 10.1016/j.ejca.2015.07.006 – ident: key20190314145725_ref65 doi: 10.1002/ijc.30031 – ident: key20190314145725_ref131 doi: 10.1038/bjc.2017.485 – ident: key20190314145725_ref114 doi: 10.1177/0969141314558785 – ident: key20190314145725_ref59 doi: 10.1111/1471-0528.14682 – ident: key20190314145725_ref132 – volume: 151 start-page: 264 year: 2009 ident: key20190314145725_ref31 article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: Ann Intern Med doi: 10.7326/0003-4819-151-4-200908180-00135 – ident: key20190314145725_ref117 doi: 10.1038/bjc.2015.11 – ident: key20190314145725_ref125 doi: 10.1038/sj.bjc.6605194 – ident: key20190314145725_ref26 doi: 10.1186/s12885-018-4165-4 – ident: key20190314145725_ref14 doi: 10.1002/ijc.22131 – ident: key20190314145725_ref29 doi: 10.7326/0003-4819-155-8-201110180-00009 – ident: key20190314145725_ref28 doi: 10.1016/j.cmi.2015.04.015 – ident: key20190314145725_ref56 doi: 10.1111/jog.13258 – ident: key20190314145725_ref50 doi: 10.1093/jnci/dju400 – ident: key20190314145725_ref79 doi: 10.1128/JCM.02440-05 – ident: key20190314145725_ref89 doi: 10.1002/ijc.25731 – ident: key20190314145725_ref63 doi: 10.1111/tmi.12549 – volume: 133 start-page: 2681 year: 2013 ident: key20190314145725_ref112 article-title: HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France publication-title: Int J Cancer – ident: key20190314145725_ref68 doi: 10.1186/s13027-017-0123-z – ident: key20190314145725_ref12 – ident: key20190314145725_ref5 doi: 10.1002/ijc.25525 – ident: key20190314145725_ref1 doi: 10.1093/annonc/mdr015 – ident: key20190314145725_ref4 doi: 10.1016/j.ejca.2009.07.018 |
| SSID | ssj0002378965 |
| Score | 2.7029648 |
| SecondaryResourceType | review_article |
| Snippet | AbstractObjectiveTo evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling... To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to reach... ObjectiveTo evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays on self samples and the efficacy of self sampling strategies to... |
| SourceID | pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | k4823 |
| SubjectTerms | Accuracy Biopsy Cellular biology Cervical cancer Cervical Intraepithelial Neoplasia - epidemiology Cervical Intraepithelial Neoplasia - pathology Clinical trials Colposcopy Colposcopy - methods Data processing Disease prevention Early Detection of Cancer - methods Early Detection of Cancer - statistics & numerical data Female Human papillomavirus Humans Incidence Intention to Treat Analysis - methods Mass Screening - methods Medical screening Meta-analysis Motivation Papillomaviridae - genetics Papillomaviridae - immunology Papillomavirus Infections - complications Papillomavirus Infections - pathology Papillomavirus Infections - virology Polymerase chain reaction Population studies Randomized Controlled Trials as Topic Reviews Sampling Self Sensitivity and Specificity Specimen Handling - methods Systematic review Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - pathology Vagina Vagina - cytology Vagina - pathology Vaginal Smears - methods Womens health |
| Title | Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses |
| URI | https://bmj.com/content/363/bmj.k4823.full https://www.ncbi.nlm.nih.gov/pubmed/30518635 https://www.proquest.com/docview/2150290805 https://www.proquest.com/docview/2161062504 https://pubmed.ncbi.nlm.nih.gov/PMC6278587 |
| Volume | 363 |
| WOSCitedRecordID | wos000452846800003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1756-1833 dateEnd: 20251004 omitProxy: false ssIdentifier: ssj0002378965 issn: 0959-8138 databaseCode: M7P dateStart: 19940108 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1756-1833 dateEnd: 20251004 omitProxy: false ssIdentifier: ssj0002378965 issn: 0959-8138 databaseCode: 7X7 dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1756-1833 dateEnd: 20251004 omitProxy: false ssIdentifier: ssj0002378965 issn: 0959-8138 databaseCode: 7RV dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1756-1833 dateEnd: 20251004 omitProxy: false ssIdentifier: ssj0002378965 issn: 0959-8138 databaseCode: BENPR dateStart: 19940108 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1756-1833 dateEnd: 20251004 omitProxy: false ssIdentifier: ssj0002378965 issn: 0959-8138 databaseCode: M2O dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1756-1833 dateEnd: 20251004 omitProxy: false ssIdentifier: ssj0002378965 issn: 0959-8138 databaseCode: M2P dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLZoixAX9tJAGRnEgUtoxok3LoilVS8dogqquY28QqHNTCcZpP57nj2elIGKCxfLip9kS89-e76H0EsblApYDjlod51XtmK5LLTLjSylVtpzo0RsNsFHIzEeyzoF3NpUVrmSiVFQ26kJMfI9UE0FkWDf0Lezizx0jQrZ1dRCYwNtgaJmoYPBEfnUx1hIyYVkNAEKDUu2p8-_v_5RidicCObryugvC_PPQsnfNM_B3f898z10J9mc-N3yktxHN1zzAN06Sln1h-jyowupBFBi2ETRAcQzkIThQsyxaiyep5pLvIj_wphQrOMsjvANWF_iUD3_FR_WJ7gLqB0wnza4dWcetyrAD7dv8GIWYgsWn7tO5SpCobj2EfpysP_5w2GeWjLkuirLLldUGXB4PGWaaanAwHDgYHrwuoi0Q-IL6biRwlBWWV9YrgWpFDVEKOelrUS5jTabaeN2EKZuKJUXhfcUFpRQnhLjSiqZ4qTyLkMD4NAkPal2Er2Vkk3Cx8jCDL1aMW9iEqB56Ktxdh3pi550tkTxuI5od8XFq12vWJih5_0yPMGQV1GNmy4CDdigLGDBZejx8sL0u4A4HQow6jLE165STxDgvddXmtNvEeabES6o4E_-fayn6DY8NxErbOgu2uzmC_cM3TQ_u9N2PkAb_PgkjGMeRzFAW-_3R_XxIL6UONZh5PUvN8sfLg |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL70egFINA6iU068SxjYQQolRbtV31UNDeguMHFNrsssmC9k_xGxl7sykLFbceuFnxKM7j8zzs8TcAz4w3Kug5xGjdyzgzWR7LpLSxlqksVem4ViIUm-CDgRgO5cEK_FychfFplQudGBS1GWm_Rr6JpimhEv0b9nr8LfZVo_zu6qKExhwWu3b2A0O2-tXOFv7f55Ruvzt824_bqgJxmaVpEyumNPrsjuVlXkqFNtJijOQwcKDS9KhLpOVaCs3yzLjE8FLQTDFNhbJOmkykeN8LcBH1OPcVE_iQd2s6NOVC5qwlMOql-WZ58uXF10yEYkjYXjZ-f3m0fyZm_mbptq__b9_oBlxrfWryZj4JbsKKrW7B5f02a-A2zLas3ypBI010UI0oPEZN7wE_IaoyZNLmlJJpOOujfTKSNSTQU5ByRvzpgE-kf_CBNJ6VBNujitT22JFaeXrl-iWZjv3aiSEntlGxClQvtr4D78_lxe_CajWq7H0gzPakciJxjmGHEsoxqm3KZK44zZyNYB0RUbQqoy5CNJbmhb8YIBPBxgIshW4J233dkOOzRJ92ouM5S8lZQmsL1JyOegqZCJ503ahi_L6Rquxo6mXQx849110E9-YA7UZBc9ET6LRGwJeg2wl4-vLlnuroc6AxzykXTPAH_36sx3Clf7i_V-ztDHYfwlVULSJkE7E1WG0mU_sILunvzVE9WQ9zkcDH8wb2L3jVdcg |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgiouvB-BUgwCiUvYrBMnNhJCiGXVqrDsAVBvqeNHW2izyyYL2r_Gr2PsTVIWKm49cIviUZ6f5xvb428AnmhHKhg5hMjuRZjoJA1FVJhQiVgUsrCZktwXm8hGI763J8Zr8LPdC-PSKluf6B21nig3R95DaoqowPiG9WyTFjEeDF9Nv4WugpRbaW3LaSwhsmsWP3D4Vr3cGeC_fkrp8O3HN9thU2EgLJI4rkPJpML43bK0SAshkS8NjpcsDiKo0H1qI2EyJbhiaaJtpLOC00QyRbk0VuiEx3jdC3AxSzDud2mD9EM3v0PjjIuUNWJG_TjtFSdfnn9NuC-MhMerRPhXdPtnkuZvrDe8-j9_r2twpYm1yetl57gOa6a8ARvvm2yCm7AYGLeEguRNlHeZaDxFBnAdYUZkqcmsyTUlc78HSLkkJaOJl60gxYK4XQMHZHv8mdROrQSPJyWpzLEllXSyy9ULMp-6ORVNTkwtQ-klYEx1Cz6dy4vfhvVyUpq7QJjpC2l5ZC3DBsmlZVSZmIlUZjSxJoAtREfeuJIq96O0OM3dSQ-fAJ61wMlVI-Tu6okcn2X6uDOdLtVLzjLabBF0etdT-ATwqGtG1-PWk2RpJnNng7F36jTwArizBGt3F6SRPsdgNoBsBcadgZM1X20pjw69vHlKM854du_fj_UQNhDP-bud0e59uIweh_skI7YJ6_Vsbh7AJfW9PqpmW75bEtg_b1z_Asd1fpo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detecting+cervical+precancer+and+reaching+underscreened+women+by+using+HPV+testing+on+self+samples%3A+updated+meta-analyses&rft.jtitle=BMJ+%28Online%29&rft.au=Arbyn%2C+Marc&rft.au=Smith%2C+Sara+B&rft.au=Temin%2C+Sarah&rft.au=Sultana%2C+Farhana&rft.date=2018-12-05&rft.pub=British+Medical+Journal+Publishing+Group&rft.issn=0959-8138&rft.eissn=1756-1833&rft.volume=363&rft_id=info:doi/10.1136%2Fbmj.k4823&rft_id=info%3Apmid%2F30518635&rft.externalDBID=BMJ-US&rft.externalDocID=bmj |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0959-8138&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0959-8138&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0959-8138&client=summon |